Not applicableEnded earlyNCT01955213What this trial is testingMethylnaltrexone for Opioid Induced ConstipationWho this might be right forConstipation Amsterdam UMC, location VUmc 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750848What this trial is testingChidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast CancerWho this might be right forAdvanced Breast Cancer Jundong Wu 48
Not applicableNot Yet RecruitingNCT06682247What this trial is testingA Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal CancerWho this might be right forColorectal Cancer Metastatic Feng Wang 200
Early research (Phase 1)Ended earlyNCT00520533What this trial is testingStudy of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma (RCC) Ludwig Institute for Cancer Research 8
Testing effectiveness (Phase 2)Study completedNCT00113334What this trial is testingStudy of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00061893What this trial is testingVinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of TumorsWho this might be right forSarcoma Children's Oncology Group 38
Not applicableStudy completedNCT02557451What this trial is testingSurgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration ComplicationsWho this might be right forSubretinal Haematoma Linked to AMD Centre Hospitalier Universitaire Dijon 91
Not applicableStudy completedNCT01690858What this trial is testingMulticentric Prospective Study of Genetic and Physiopathology Concerning Dysregulation of Complement During Repeated Fetal AbortionsWho this might be right forFetal Losses Nantes University Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03851614What this trial is testingStudy of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid TumorsWho this might be right forMismatch Repair Proficient Colorectal CancerPancreatic AdenocarcinomaLeiomyosarcoma University Health Network, Toronto 90
Testing effectiveness (Phase 2)Ended earlyNCT00307723What this trial is testingStudy of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerWho this might be right forPancreatic CancerPancreatic Ductal Adenocarcinoma Massachusetts General Hospital 52
Early research (Phase 1)Ended earlyNCT00769093What this trial is testingAssessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving ChemotherapyWho this might be right forBrain Neoplasms OHSU Knight Cancer Institute 6
Early research (Phase 1)Study completedNCT00390156What this trial is testingImatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsWho this might be right forUnspecified Adult Solid Tumor University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00655785What this trial is testingAntiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)Who this might be right forPancreatic Cancer Fukushima Medical University 17
Very early researchStudy completedNCT02806817What this trial is testingME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial MetabolismWho this might be right forBreast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEarly-Stage Breast Carcinoma Centro Nacional de Investigaciones Oncologicas CARLOS III 40
Early research (Phase 1)Study completedNCT01507480What this trial is testingThe ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic TelangiectasiaWho this might be right forRendu Osler DiseaseTelangiectasia, Hereditary Hemorrhagic Hospices Civils de Lyon 42
Early research (Phase 1)Study completedNCT00822848What this trial is testingSorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue SarcomaWho this might be right forSarcoma OHSU Knight Cancer Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT06976944What this trial is testingPembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast CancerWho this might be right forRecurrent Triple-Negative Breast Cancer Yukinori Ozaki 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05824481What this trial is testingStudy of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial CancerWho this might be right forEndometrial CancerEndometrial Adenocarcinoma Sun Yat-sen University 32
Not applicableUnknownNCT06062563What this trial is testingStudy of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid CancerWho this might be right forLocally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Peking Union Medical College Hospital 10
Not applicableEnded earlyNCT02841332What this trial is testingMultimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent GlioblastomaWho this might be right forGlioblastoma University Hospital, Toulouse 6